La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Pacific Biosciences a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Pacific Biosciences..

Pacific Biosciences (NASDAQ:PACB) Azioni, Catena delle Opzioni

PACIFIC BIOSCIENCES OF CALIF

Pacific Biosciences

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Russia,Moscow,24.06.2021,Logo,Of,Financial,Investing,Fund,Ark,Invest

Equities

News

Markets

ETFs

ARKK

ARKW

ARKX

CRSP

KTOS

PACB

PLTR

SHOP

Movimenti sui fondi ETF della nota investitrice. Cessioni del titolo AI, acquisti mirati su chip ed e-commerce. Attività anche su biotech.

Cathie Wood vende Palantir prima degli utili e acquista questi 2 titoli

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences of California Inc

Health Care

Press Releases

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

General

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Analyst Ratings

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

PacBio to Present at Upcoming Investor Conferences

Earnings

PacBio Announces Second Quarter 2025 Financial Results

PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow

PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs

Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A

Bruker

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Pacific Biosciences

Pacific Biosciences (PACB) Opzioni

Pacific Biosciences (NASDAQ:PACB) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO